跳至主要内容
临床试验/NCT05521529
NCT05521529招募中不适用

Effects of CORtisol Excess and REmission in Cushing's Syndrome Over Time (CORRECT): A Prospective Non-interventional Cohort Study

University of Aarhus1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年2月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Change in CushingQoL-score

研究概览

简要总结

The purpose of this study is to prospectively study patients with Cushing's syndrome before and after treatment, with a special emphasis on physical function, quality of life, and circadian rhythms.

The hypotheses are:

  • Cushing's syndrome negatively impacts health-related quality of life (HRQoL) and physical functioning
  • Cushing's syndrome is associated with altered circadian rhythms at the whole body level and in peripheral target tissues.
  • These complications partially reverse following disease control.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New (≤ 2 months) diagnosis of Cushing's syndrome (CS) of endogenous etiology:
  • ACTH-dependent CS
  • ACTH-independent CS
  • Age >18 years
  • Written informed consent

排除标准

  • Active cancer
  • Iatrogenic or malignant cause of CS such as adrenocortical carcinoma
  • Chronic heart failure (New York Heart Association class IV)
  • Chronic kidney disease Chronic Kidney Disease stage ≥3 (eGFR >30 ml/min)
  • Liver disease in the form of cirrhosis
  • Deemed unable to complete the study safely by investigator

结局指标

主要结局

Change in CushingQoL-score

时间窗: Baseline, 3 months after and 1 year after treatment

Questionnaire filled out by patients

次要结局

  • Change in Insulin resistance(Baseline, 3 months after and 1 year)
  • Change in Vertebral Fracture Assessment(Baseline, 3 months after and 1 year)
  • Change in total physical activity(Baseline, 3 months after and 1 year)
  • Change in 24 hour urinary adreneric metabolites(Baseline, 3 months after and 1 year)
  • Change in 24 hour urinary free cortisol(Baseline, 3 months after and 1 year)
  • Change in Hba1C(Baseline, 3 months after and 1 year)
  • Change in Messenger RNA expression of core clock genes in blood leukocytes and biopsies of skeletal muscle and adipose tissue.(Baseline, 3 months after and 1 year)
  • Change in total sleep time(Baseline, 3 months after and 1 year)
  • Change in Bone Mineral Density(Baseline, 3 months after and 1 year)
  • Change in weight(Baseline, 3 months after and 1 year)
  • Change in Sedentary time(Baseline, 3 months after and 1 year)
  • Change in IPAQ-S7S(Baseline, 3 months after and 1 year)
  • Change in blood pressure(Baseline, 3 months after and 1 year)
  • Change in Hospital Anxiety and Depression Scale (HADS) score(Baseline, 3 months after and 1 year after treatment)
  • Change in arterial stiffness and endothelial function.(Baseline, 3 months after and 1 year)
  • Change in endothelial function.(Baseline, 3 months after and 1 year)
  • Change in body composition(Baseline, 3 months after and 1 year)
  • Change in BMI(Baseline, 3 months after and 1 year)
  • Change in Timed up and go (TUG)-test(Baseline, 3 months after and 1 year)
  • Change in Single item Sleep Quality Scale (SQS) score(Baseline, 3 months after and 1 year)
  • Change in hip circumference(Baseline, 3 months after and 1 year)
  • Change in waist circumference(Baseline, 3 months after and 1 year)
  • Change in Short Physical Performance Battery (SPPB) and chair rising test - score(Baseline, 3 months after and 1 year)
  • Change in Handgrip strength(Baseline, 3 months after and 1 year)
  • FACS of blood leukocytes(Baseline, 3 months after and 1 year)
  • Change in 24 hour urinary steroid metabolome(Baseline, 3 months after and 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Cushing's Syndrome Before and After Treatment... | 临床试验